Skip to main content
. 2019 Jun 12;14(6):e0217597. doi: 10.1371/journal.pone.0217597

Table 5. Multidrug resistance patterns in drug-resistant culture positive TB cases with DST results, by country of birth and age group (for cases with available information), Germany 2008–2017, Isoniazid/H, Rifampicin/R, Pyrazinamide/Z, Ethambutol/E, and Streptomycin/S.

Age group: < 15 yr.
Country of birth Total No. of TB cases MDR-TB present HR only 3 drugs 4 drugs All 5 drugs
N % N N N N
Germany 366 6 1.6% 0 2 2 2
Other 209 8 3.8% 1 1 2 4
Total 575 14 2.4% 1 3 4 6
Age group: 15–39 yr.
Total No. of TB cases MDR-TB present HR only 3 drugs 4 drugs All 5 drugs
N % N N N N
Germany 1,979 19 1.0% 2 6 3 8
Other 8,323 318 3.8% 27 71 79 141
Total 10,302 337 3.3% 29 77 82 149
Age group: 40–59 yr.
Total No. of TB cases MDR-TB present HR only 3 drugs 4 drugs All 5 drugs
N % N N N N
Germany 3,449 29 0.8% 5 10 7 7
Other 3,542 122 3.4% 11 36 33 42
Total 6,991 151 2.2% 16 46 40 49
Age group: 60+ yr.
Total No. of TB cases MDR-TB present HR only 3 drugs 4 drugs All 5 drugs
N % N N N N
Germany 5,174 16 0.3% 3 1 6 6
Other 2,525 30 1.2% 5 12 9 4
Total 7,699 46 0.6% 8 13 15 10
All age groups
Total No. of TB cases MDR-TB present HR only 3 drugs 4 drugs All 5 drugs
N % N N N N
Germany 10,969 70 0.6% 10 19 18 23
Other 14,600 478 3.3% 44 120 123 191
Total 25,569 548 2.1% 54 139 141 214